[Viral deafness. Its prognosis and treatment].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001645:Biguanides / Q000627:therapeutic use; D004279:DNA, Viral / Q000378:metabolism; D003638:Deafness / Q000188:drug therapy* / Q000209:etiology*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use; D009113:Muramidase / Q000627:therapeutic use; D011379:Prognosis; D012367:RNA, Viral / Q000378:metabolism; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014777:Virus Diseases / Q000150:complications* / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D001645:Biguanides; D004279:DNA, Viral; D012367:RNA, Viral; D013882:Thiosemicarbazones; D007372:Interferons; D009113:Muramidase
Sorderas viriasicas. Su pronóstico y tratamiento.